Jonathan Seccombe, MD
Gastroenterology · Saint Louis, MONPI 1124255849
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $523 of the $717 with a category attached, or 72.9%. It is spread thinly across 11 manufacturers, the largest accounting for just 23.2%. Reporting peaked in 2022 at $301 and has fallen 93.9% since, to $18 in 2025. That places this record below the midpoint for gastroenterology clinicians in MO, where the typical reported total is $1,415.
Across 45 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$166
- Braintree Laboratories, Inc.$137
- Johnson & Johnson$124
- E.r. Squibb & Sons, L.L.C.$81
- Nestle Healthcare Nutrition Inc.$70
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$37
- plus $102 from 5 others
What the payments were for
- Food & beverage$52373%
- Education$578%
- Gifts$13719%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $166 |
| Braintree Laboratories, Inc. | 19 | $137 |
| Johnson & Johnson | 5 | $124 |
| E.r. Squibb & Sons, L.L.C. | 1 | $81 |
| Nestle Healthcare Nutrition Inc. | 4 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Sanofi | 1 | $26 |
| Amgen | 1 | $19 |
| Bristol Myers Squibb | 1 | $17 |
| Olympus America Inc. | 1 | $14 |
How this compares
$717 in reported general payments places this provider in the 35th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 17 | $329 |
| Famotidine | 14 | $304 |
| Pantoprazole Sodium | 42 | $278 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Saint Louis
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$730K
- David AlpersSaint Louis$616K
- Parakkal DeepakSaint Louis$205K
- Mauricio Lisker MelmanSaint Louis$179K
- Matthew CiorbaSaint Louis$156K
- Bruce BaconSaint Louis$138K
- Jeffrey CrippinSaint Louis$120K
- Vladimir KushnirSaint Louis$118K
- Kayci Huff-HardySaint Louis$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.